MN
Monica Nesselbush
Resero Bio, Personal Genome Diagnostics, Stanford University, Harvard University
Research areas: Biochemistry, Genetics and Molecular Biology · Cancer Research · Cancer Genomics and Diagnostics · Lung Cancer Treatments and Mutations · Lung Cancer Diagnosis and Treatment
0000-0003-4818-2301
Employment
-
Resero Bio CEO & Co-founder
-
Personal Genome Diagnostics Assistant Scientist
Education
- 2017 - Present
- 2010 - 2014
Projects & Funding
Projects & funding information is unavailable.
Publications (19)
- An ultrasensitive method for detection of cell-free RNA Save
- A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease Save
- ULTRASENSITIVE URINARY LIQUID BIOPSY ANALYSIS FOR BCG RESPONSE ASSESSMENT IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER Save
- An Integrated Multimodal Framework for Noninvasive TCL Disease Detection and Monitoring Save
- Data from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition Save
- Data from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition Save
- Supplementary Figures 1-9 from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition Save
- Supplementary Figures 1-9 from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition Save
- Supplementary Tables S1-S7 from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition Save
- Supplementary Tables S1-S7 from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition Save
- Inferring gene expression from cell-free DNA fragmentation profiles. Save
- Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer. Save
- KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition Save
- KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer. Save
- Integrating genomic features for non-invasive early lung cancer detection Save
- Direct detection of early-stage cancers using circulating tumor DNA. Save
- The genomic landscape of response to EGFR blockade in colorectal cancer. Save
- Personalized genomic analyses for cancer mutation discovery and interpretation. Save
- Lower nasopharyngeal epithelial cell repair and diminished innate inflammation responses contribute to the onset of acute otitis media in otitis-prone children. Save